Reflections from the 2026 Veeva R&D Summit Sweta Pittala Vice President, Technology Portfolio, IT R&D AI is advancing rapidly across clinical research, but moving from promising demonstrations to sustainable, real-world impact remains a significant challenge. At the 2026 Veeva R&D Summit, Chief Operations Officer Nicholas Spittal and I shared Velocity Clinical Research’s experience putting AI … Read more
Dr. Amy McCoy’s first real exposure to research came from her own hospital bed — on bed rest with a preeclampsia diagnosis during her pregnancy, when a gynecologic oncologist in her training program pulled her onto a research project and taught her grants and study design. Years later, research found her again through pregnancy, this … Read more
Justin brings more than two decades of experience as a healthcare operator, with a track record of scaling multisite services businesses and delivering strong outcomes for investors Paul Evans continues as Chair of the Board to support Velocity’s growth strategy as it enters its next phase The appointment reinforces Velocity’s mission to improve the clinical … Read more
Full network expansion to all studies at 70+ global locations follows a year-long collaboration that improved show-rates by up to 9 percentage points across nearly 100k scheduled screenings. Today, we are excited to announce that Velocity Clinical Research, the world’s largest organization of fully owned and integrated clinical research sites, is deepening its aligned partnership … Read more
By Nick Spittal, Chief Operations Officer, Velocity Clinical Research Most sponsors and CROs talk about slow sites, hard-to-find patients, and protocol complexity putting their studies at risk. Those issues are all real, and they frequently share the same underlying cause: the disparate operating model used across individual study sites. In my experience, study risk often … Read more
Velocity Clinical Research, the world’s largest integrated global site network, today announced that its centralized Electronic Data Capture (EDC) model is now entering 97% of clinical trial data within one business day of patient visits — two to four days faster than the industry average of five days reported in independent benchmarking studies. Additionally, data … Read more
By Tyler Beasley, Executive Director, Business Intelligence Over the last several years, clinical research organizations have invested heavily in business intelligence infrastructure. Enterprise reporting has replaced manually maintained spreadsheets and datasets. Data warehouses have helped to partially bridge the gap with previously disconnected systems. Dashboards now deliver visibility into nearly every aspect of study execution, … Read more
Michael Zimmerman, MD, will tell you that he is impatient, with about as much fanfare as someone might mention they’re left-handed. He chose emergency medicine partly because of that trait: the ER moves fast, emergency medics get to travel in helicopters, and nobody makes you wait two days for a lab result. That fast-paced world … Read more
When a large-scale vaccine trial needed to move fast, Velocity delivered — not once, but twice, across two continents. In the United States, Velocity was the sole site network selected to enroll participants for the trial. Across just 10 sites, the team enrolled 1,000 participants in 3.5 weeks. That’s the kind of speed that only … Read more
By Sweta Pittala, VP, Technology Portfolio Management At a Glance Responding to Requests for Proposal (RFPs) is one of the most labor-intensive processes in clinical trial operations. Velocity’s Feasibility Agent automates and augments that process, drawing on years of data on site performance from 70+ global sites, PI experience, and local recruitment trends to produce … Read more